Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
04/2007
04/26/2007US20070093424 drugs that bind and neutralize bacterial lipopolysaccharides, used for prevention or treatment of endotoxic shock or sepsis
04/26/2007US20070093423 Process for production of Bivalirudin
04/26/2007US20070093422 Drug comprising synthetic peptide analogs for the treatment of cancer
04/26/2007US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent
04/26/2007US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2
04/26/2007US20070093415 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques
04/26/2007US20070093412 Pharmaceutical composition comprising cyclic somatostatin analogues
04/26/2007DE102005049637A1 Antagonisten gegen die Interaktion von PF4 und RANTES Antagonists to the interaction of PF4 and RANTES
04/26/2007DE102005049537A1 New cyclic peptides, useful e.g. as antibiotics and in cosmetics, are prepared by synthesis of linear peptide from selected starter amino acid then cyclization
04/25/2007EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
04/25/2007EP1777232A1 Purified leuprorelin
04/25/2007EP1776380A2 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity
04/25/2007EP1776133A1 Peptidic vasopressin receptor agonists
04/25/2007EP1776130A2 Pin1-modulating compounds and methods of use thereof
04/25/2007EP1476463B1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
04/25/2007EP1254174B1 Human cyr61
04/25/2007EP1000177B1 Synthetic antigens for the detection of antibodies having immunoreactivity against hiv virus
04/25/2007EP0960887B1 T cell epitope peptides
04/25/2007EP0804468B1 Method of making an omega-functionalized amino acid derivative
04/25/2007CN1954073A Modified Bouganin proteins, cytotoxins and methods and uses thereof
04/25/2007CN1954068A HLA-binding peptide, precursor thereof, DNA fragment encoding the same and recombinant vector
04/25/2007CN1953990A Cyclopeptide derivatives with anti-integrin activity
04/25/2007CN1953989A Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
04/25/2007CN1953988A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides
04/25/2007CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
04/25/2007CN1312178C High density lipoprotein-reactive peptides
04/25/2007CN1312173C Section of synthesized peptide S28-42 of troponin I of human cardiac muscle and application
04/24/2007US7208600 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
04/24/2007US7208476 Use of pseudopeptide analogs which inhibit insect juvenile hormone biosynthesis and the use of such analogs for insect control
04/24/2007US7208289 Receptor binding assay wherein binding to the CLLD8 protein identifies the compound as being an agonist or antagonist
04/24/2007US7208279 Method for identifying inhibitors of G protein coupled receptor signaling
04/24/2007US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
04/24/2007US7208149 IL-16 antagonist peptides and DNA encoding the peptides
04/24/2007CA2277832C Cyclic peptides that bind to urokinase-type plasminogen activator receptor
04/24/2007CA2151933C A proteinase inhibitor, precursor thereof and genetic sequences encoding same
04/24/2007CA2114849C Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects
04/19/2007WO2007044001A1 Amino acid-containing compounds and derivatives labeled with halides and method of making
04/19/2007WO2007043715A1 Rna-binding peptide
04/19/2007WO2007042254A1 C-krox peptides and analogs thereof for treating skin ageing
04/19/2007WO2007022531A9 Methods and compositions for the treatment of gastrointestinal disorders
04/19/2007WO2006127948A3 N-terminally modified glp-1 receptor modulators
04/19/2007WO2006039668A3 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
04/19/2007WO2004058189A3 Chemokine antagonists and uses thereof
04/19/2007US20070087973 producing (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide, used as serine protease inhibitors, useful for treatment of hepatitis C virus infections
04/19/2007US20070087972 Prion-specific peptoid reagents
04/19/2007US20070087971 Peptides, derivatives and analogs thereof, and methods of using same
04/19/2007US20070087963 Synthesis of cyclosporin analogs
04/19/2007US20070087409 Angiotensin peptide-carrier conjugates and uses thereof
04/19/2007US20070087380 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
04/19/2007US20070087371 Zinc finger domains and methods of identifying same
04/19/2007US20070086981 Delivery peptides, their constructs with active agents and use
04/19/2007CA2624990A1 Ckrox peptides and analogs thereof for treating skin ageing
04/18/2007EP1775306A1 cKrox peptides and analogs thereof for treating skin ageing
04/18/2007EP1773871A2 Tdf-related compounds and analogs thereof
04/18/2007EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
04/18/2007EP1773699A2 Napkin dispenser
04/18/2007EP1419174B1 Process for preparing glycopeptide derivatives
04/18/2007CN1950394A Method for inhibiting immune complex formation in a subjetc
04/18/2007CN1948333A New hPEBP4 protein source HLA-A2 limiting epi-polypeptide and its application
04/18/2007CN1311238C Hypotensors
04/17/2007US7205383 Peptide ligands of leukocyte integrins
04/17/2007US7205382 Solid phase synthesis; for autoimmune diseases, rheumatoid diseases, multiple sclerosis, and myasthenia gravis
04/17/2007US7205275 Methods of treatment using specific binding agents of human angiopoietin-2
04/17/2007US7205273 Fusogenic liposomes
04/17/2007US7205120 Detection Alzheimer's disease
04/17/2007US7205119 HA-1 antigen
04/17/2007CA2211314C A process for preparing certain aza cyclohexapeptides
04/17/2007CA2184175C Isolated, tyrosinase derived peptides and uses thereof
04/17/2007CA2133205C Stable polypeptide composition
04/17/2007CA2123912C Muramyl compounds for treatment of septic shock
04/12/2007WO2007041631A1 ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION
04/12/2007WO2007040131A1 Composition for controlling common scab of agricultural crop containing surfactin
04/12/2007WO2007039728A2 AVß6 PEPTIDE LIGANDS AND THEIR USES
04/12/2007WO2007039489A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
04/12/2007US20070082860 Hla-a24-restricted cancer antigen peptides
04/12/2007US20070082849 Angiogenic peptides and uses thereof
04/12/2007US20070082839 Peptide increasing fusiogenic capacity of a gamete
04/12/2007US20070081991 Compositions and methods for modulation of immune responses
04/12/2007CA2854550A1 Av.beta.6 peptide ligands and their uses
04/12/2007CA2624618A1 Av.beta.6 peptide ligands and their uses
04/12/2007CA2623864A1 Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection
04/12/2007CA2623530A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
04/11/2007EP1053248B1 Peptide structures and their use in diagnosis of herpes simplex virus type 2
04/11/2007CN1946737A Functional method for generating or screening for ligands which modulate steroid hormone receptors
04/11/2007CN1946690A Cyclobutenedione groups-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
04/11/2007CN1943781A Orally administered peptides to ameliorate atherosclerosis
04/10/2007US7202351 Alteration of immune response using pan DR-binding peptides
04/10/2007US7202333 Recombinant soluble fragment of the alpha-subunit polypeptide of human mast cell IgE surface receptor, capable of binding to human IgE; can be used in diagnostic, drug screening and antiallergen applications
04/10/2007US7202331 For inducing immune response and administering immunotherapy
04/10/2007US7202330 RGD (Arg-Gly-Asp) coupled to (neuro)peptides
04/10/2007US7202227 Multifunctional molecular complexes for gene transfer to cells
04/10/2007US7202215 Long-acting follicle stimulating hormone analogues and uses thereof
04/10/2007US7202050 Measuring protein kinase or phosphatase activity in a sample with a reporter peptide, or a fluorescently-labeled phosphorylatable reporter peptide, cleaved by a protease, without using antibodies or radioactive labels
04/10/2007US7201904 Epitopes of hepatitis C virus
04/10/2007US7201903 Method and device for detecting feline immunodeficiency virus
04/10/2007US7201892 using carbocyanine dyes; photodynamic therapy; supplying to tumors
04/10/2007CA2226880C Cyclosporin derivatives with anti-hiv effect
04/10/2007CA2197209C Aza cyclohexapeptide compounds
04/10/2007CA2190108C Somatostatin binding peptide-metal chelate conjugates
04/10/2007CA2150816C Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications